Skip to content

Tuesday, November 5, 2024

Latest:

Mental health impacts overall health in older adults
How to cope when your pet dies
Medical residency and advocacy: Even small contributions can have a significant impact
Medical student-mentor teams in research: Shubh Desai and Dr. Nandan Mondal share their experience with SOAR
What is fracture-related infection? Causes, symptoms and treatment options

Home
Momentum
From The Labs
- About From the Labs
- Follow From The Labs on Twitter
Policywise
- About PolicyWise
- Follow @BCMEthics on Twitter
The Stitch
- About The Stitch
Progress Notes
bcm.edu

castration-resistant prostate cancer

Targeting MAPK4 emerges as a promising therapy for prostate cancer

February 23, 2021 Akt pathway, androgen receptor, cancer therapy, castration-resistant prostate cancer, MAPK4, Prostate Cancer, Research

Inhibiting MAPK4 simultaneously inactivated both androgen receptor and AKT and stopped cancer growth in animal models.

From the Labs: Image of the Month

From the Labs: Aging signs.

Healthy Habits: A DOC-umentary Series

Archives

Archives

Search

©1998 - 2023 Baylor College of Medicine®
One Baylor Plaza, Houston, Texas 77030
(713) 798-4951